$1.2688
0.0338[2.74%]
At close: Apr 16
$1.2688
0[0.00%]
PreMarket: 4:03PM EDT
Biodesix
(NASDAQ:BDSX)Latest News for Biodesix Stock (NASDAQ:BDSX)
Biodesix Stock (NASDAQ: BDSX)
Categories: All
Tuesday, April 09, 2024
Friday, April 05, 2024
- S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike HigherAvi Kapoor - Apr 5, 2024, 2:20PM
- Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Apr 5, 2024, 1:06PM
- Gold Surges Over 1%; Biodesix Shares PlummetAvi Kapoor - Apr 5, 2024, 12:06PM
- Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In MarchAvi Kapoor - Apr 5, 2024, 9:50AM
- Biodesix shares are trading lower after the company announced pricing of its oversubscribed and upsized underwritten offering of common stock and concurrent private placement.Benzinga Newsdesk - Apr 5, 2024, 8:36AM
- Biodesix Priced Its Underwritten Offering Of 17.4M Shares At $1.15/Share And Announced Concurrent Private Placement Of 760,857 Shares Of Its Series A Non-voting Convertible Preferred Stock At $46/Share, With Gross Proceeds Of $55MBenzinga Newsdesk - Apr 5, 2024, 7:20AM
Monday, March 04, 2024
Friday, March 01, 2024
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 1, 2024, 8:09AM
- Earnings Scheduled For March 1, 2024Benzinga Insights - Mar 1, 2024, 6:56AM
- Biodesix Sees FY24 Revenue Of $65M-$68M (Estimate: $64.53M), Representing Approximate 32%-39% Year-over-year Growth RateBenzinga Newsdesk - Mar 1, 2024, 6:06AM
- Biodesix: Q4 Earnings InsightsBenzinga Insights - Mar 1, 2024, 6:05AM
- Biodesix Q4 EPS $(0.10) Beats $(0.11) Estimate, Sales $14.67M Miss $15.61M EstimateBenzinga Newsdesk - Mar 1, 2024, 6:02AM
Thursday, February 29, 2024
Thursday, December 07, 2023
Tuesday, November 07, 2023
- Biodesix Sees FY23 Revenue $50M-$52M Vs $53.29M Est.Benzinga Newsdesk - Nov 7, 2023, 7:31PM
- Recap: Biodesix Q3 EarningsBenzinga Insights - Nov 7, 2023, 4:20PM
- Biodesix Q3 2023 EPS $(0.14) Beats $(0.15) Estimate, Sales $13.49M Miss $14.36M EstimateBenzinga Newsdesk - Nov 7, 2023, 4:15PM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Tuesday, October 03, 2023
Thursday, September 07, 2023
Thursday, August 24, 2023
Monday, August 07, 2023
- Biodesix Reaffirms 2023 Revenue Guidance $52M-$55MBenzinga Newsdesk - Aug 7, 2023, 5:06PM
- Biodesix Q2 EPS $(0.17) Beats $(0.21) Estimate, Sales $11.87M Beat $11.38M EstimateBenzinga Newsdesk - Aug 7, 2023, 4:05PM
- Top 5 Health Care Stocks That May Crash In Q3Lisa Levin - Aug 7, 2023, 8:15AM
- Earnings Scheduled For August 7, 2023Benzinga Insights - Aug 7, 2023, 4:12AM
Thursday, July 27, 2023
- President & CEO at Biodesix Acquires Company Stock Options Worth 446,584 SharesBenzinga Insights - Jul 27, 2023, 11:00AM
- CFO at Biodesix Acquires Company Stock Options Worth 160,101 SharesBenzinga Insights - Jul 27, 2023, 11:00AM
- Biodesix Chief Commercial Officer Awarded $73K Worth of Stock OptionsBenzinga Insights - Jul 27, 2023, 11:00AM
- Chief Development Officer at Biodesix Acquires Company Stock Options Worth 36,786 SharesBenzinga Insights - Jul 27, 2023, 11:00AM
- Biodesix Chief Accounting Officer Awarded $30K Worth of Stock OptionsBenzinga Insights - Jul 27, 2023, 11:00AM
Thursday, July 06, 2023
Tuesday, May 30, 2023
Friday, May 26, 2023
Thursday, May 11, 2023
Tuesday, April 04, 2023
Wednesday, March 15, 2023
Thursday, March 09, 2023
Monday, March 06, 2023
- Biodesix Adjusted EPS $(0.28) (Adjusted EPS Excludes $4m or $0.07 Per Share Of Loss On Debt Extinguishment And Modification)Benzinga Newsdesk - Mar 6, 2023, 6:48AM
- Biodesix Sees FY23 Revenue Guidance Of $52M-$55M Vs. $52.51M EstimateBenzinga Newsdesk - Mar 6, 2023, 6:14AM
- Biodesix Q4 EPS $(0.35) Misses $(0.28) Estimate, Sales $9.61M Miss $10.77M EstimateBenzinga Newsdesk - Mar 6, 2023, 6:04AM
- Earnings Scheduled For March 6, 2023Benzinga Insights - Mar 6, 2023, 4:52AM